Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells.
- AnnotationStudies confirmed elevated expression of three target antigens RAB38 TBCE and DUSP12 in CML.
- CategoriesSequences, Disease & Variants
- SourceGeneRif: 23682